Maxillary Sinusitis: Clinical Trials

15 trials for Maxillary Sinusitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 4 unknown, 2 recruiting, 1 not yet recruiting. 6 Not applicable, 4 Phase 3, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable6Unknown 3, Recruiting 2, Completed 1
Phase 34Completed 4
Phase 42Completed 1, Terminated 1

Follow Maxillary Sinusitis: new trials by email Literature Review of Maxillary Sinusitis trials Research Report on Maxillary Sinusitis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Deviated Nasal Septum Effect on Maxillary Sinus Volumes and Development of Maxillary Sinusitis by CT
Deviated Nasal Septum and Maxillary Sinusitis
Not yet recruitingAssiut University1202025-10-012025-10-07
Assessment of Relationship Between Maxillary Sinus Floor and Maxillary Posterior Teeth Root Tips Position
CBCT software - Maxillary Sinusitis
UnknownCairo University1322021-10-012021-05-27
Balloon Sinuplasty Efficiency in Maxillary Rhinosinusitis.
Balloon sinuplasty of maxillary sinuses, Sham surgery - Maxillary Sinusitis, Sinusitis, Chronic
Not applicableRecruitingTampere University Hospital1202021-06-012022-10-20
Endoscopic Sinus Surgery in Recurrent Acute Rhinosinusitis
Endoscopic sinus surgery (ESS) - Maxillary Sinusitis, Sinusitis, Acute
Not applicableUnknownOulu University Hospital802020-05-012023-05-31
Single-step Functional Sinus Endoscopy and Transoral Surgery
Single-step Functional Sinus Endoscopy and Transoral Surgery, Functional sinus endoscopy, Trans oral Surgery - Maxillary Sinusitis
Not applicableRecruitingQassim University362018-11-112026-06-09
Endosseous Oroantral Port for Minimal Intervention in Treating Chronic Sinusitis
treatment of chronic maxillary sinusitis using DIVA system, "dynamic implant valve approach" - DIVA system - Maxillary Sinusitis
Not applicableUnknownWestern Galilee Hospital-Nahariya202017-03-012017-03-20
Study Designed to Clinically Evaluate Sinus Wash Device Prototypes
SinuSafe Medical Device for Maxillary Sinus - Sinusitis, Maxillary Sinusitis
Not applicableUnknownSinuSafe Medical LTD502017-01-012016-10-13
Non-Interventional Open Label Prospective Comparative Observational Study Of Evaluation Of Compliance In The Empiric Treatment With Azithromycin SR Versus Amoxiclav 1000 Mg In Adult Patients With Of Acute Bacterial Maxillary Sinusitis
Azithromycin SR, Amoxiclav 1000 mg - Maxillary Sinusitis
CompletedPfizer1232010-04-012012-04-16
Microarray Analysis of Sinus Samples From Patients With and Without Chronic Rhinosinusitis
Specimen collection - Maxillary Sinusitis
Not applicableCompletedUniversity of California, San Francisco202007-10-012020-02-05
Study to Measure the Impact of Antibiotics on Bacterial Flora in Adults With Acute Sinusitis
Azithromycin, Telithromycin - Maxillary Sinusitis
Phase 4TerminatedCPL Associates1922005-12-012007-10-31
Trial to Evaluate Time to Symptom Relief and Elimination of Infecting Bacteria in Treating Sinusitis With Avelox
Avelox (Moxifloxacin, BAY12-8039) - Maxillary Sinusitis
Phase 4CompletedBayer1922004-06-012014-12-19
A Study Evaluating the Safety and Efficacy of Treating Sinus Infection With Levofloxacin 750 mg for 5 Days.
levofloxacin - Maxillary Sinusitis
Phase 3CompletedJohnson & Johnson Pharmaceutical Research & Development, L.L.C.182003-11-012011-06-10
A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Sinus Infections in Adults
azithromycin SR (Zithromax; compound: CP-62,993), placebo, levofloxacin - Maxillary Sinusitis
Phase 3CompletedPfizer5412003-01-012011-05-11
AMS VS MOXI Ketek vs Avelox in AMS
Telithromycin - Maxillary Sinusitis
Phase 3CompletedSanofi3512002-12-012012-02-17
A Study of the Safety and Effectiveness of Levofloxacin Compared With Amoxicillin/Clavulanate Potassium in the Treatment of Adults With Rapid Onset of Severe Inflammation/Infection of the Sinuses
levofloxacin - Sinusitis, Maxillary Sinusitis
Phase 3CompletedJohnson & Johnson Pharmaceutical Research & Development, L.L.C.6141993-08-012011-06-10

Narrower conditions

Sinusitis (7)  ·  Paranasal Sinus Diseases (2)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Focal Facial Dermal Dysplasias (1)  ·  Hypersensitivity (1)  ·  Infections (1)  ·  Nose Diseases (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)

Broader conditions

Otorhinolaryngologic Diseases (15)  ·  Infections (14)  ·  Nose Diseases (14)  ·  Respiratory Tract Diseases (14)  ·  Respiratory Tract Infections (14)  ·  Paranasal Sinus Diseases (13)  ·  Sinusitis (8)  ·  Immune System Diseases (2)  ·  Abnormalities, Multiple (1)  ·  Bronchial Diseases (1)  ·  Bronchiolitis (1)  ·  Bronchiolitis Obliterans (1)  ·  Bronchitis (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)

Interventions

Levofloxacin (3)  ·  Azithromycin (2)  ·  telithromycin (2)  ·  Moxifloxacin (1)  ·  Specimen Handling (1)

Sponsors

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (2)  ·  Pfizer (2)  ·  Assiut University (1)  ·  Bayer (1)  ·  CPL Associates (1)  ·  Cairo University (1)  ·  Oulu University Hospital (1)  ·  Qassim University (1)  ·  Sanofi (1)  ·  SinuSafe Medical LTD (1)  ·  Tampere University Hospital (1)  ·  University of California, San Francisco (1)  ·  Western Galilee Hospital-Nahariya (1)

Countries

United States (5)  ·  Argentina (2)  ·  Finland (2)  ·  Chile (1)  ·  Costa Rica (1)  ·  Czechia (1)  ·  Estonia (1)  ·  Germany (1)  ·  India (1)  ·  Israel (1)  ·  Lithuania (1)  ·  Mexico (1)  ·  Poland (1)  ·  Russia (1)  ·  Saudi Arabia (1)

Top investigators

Ahmed Abdelaleem (1)  ·  Andrew Goldberg, MD, MSCE (1)  ·  Dina F Abdelrahim, Ass. Prof. (1)  ·  Ghada A Khalifa, professor (1)  ·  Itzhak Braverman, Professor (1)  ·  Jerome J Schentag, Pharm.D. (1)  ·  Johanna Luukkanen, MD (1)  ·  Joseph Paladino, Pharm.D. (1)  ·  Markus Rautiainen, Professor (1)  ·  Olli-Pekka Alho, MD, PhD (1)

Results publications

PMID 17178300, PMID 28245851, PMID 34496924, PMID 42313411, PMID 9263892